Dosimetric Analysis of 177Lu-Dota-rituximab in Patients with Relapsed/refractory Non-Hodgkin’s Lymphoma
Nuclear Medicine Communications（2016）
Key words
dosimetry,Lu-177-DOTA-rituximab,non-Hodgkin's lymphoma,radioimmunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined